FACILITATORS AND BARRIERS TO UPTAKE OF CHILD-FRIENDLY 3 MONTHS OF ISONIAZID AND RIFAMPICIN (3HR) FIXED DRUG COMBINATION (FDC) FOR TUBERCULOSIS PREVENTIVE THERAPY (TPT) IN NIGERIA
Rupert Eneogu, Austin Ihesie, Olugbenga Daniel, Ogoamaka Chukwuogo, Debby Nongo, Aderonke Agbaje, Bethrand Odume, Joseph Kuye, Omosalewa Oyelaran, Daniel Egbule, Wayne Van Gemert, Lucy Mupfumi, Cleophas D’auvergne, Obioma Chijioke-Akaniro, Chukwuma Anyaike, Sunday Olarewaju
{"title":"FACILITATORS AND BARRIERS TO UPTAKE OF CHILD-FRIENDLY 3 MONTHS OF ISONIAZID AND RIFAMPICIN (3HR) FIXED DRUG COMBINATION (FDC) FOR TUBERCULOSIS PREVENTIVE THERAPY (TPT) IN NIGERIA","authors":"Rupert Eneogu, Austin Ihesie, Olugbenga Daniel, Ogoamaka Chukwuogo, Debby Nongo, Aderonke Agbaje, Bethrand Odume, Joseph Kuye, Omosalewa Oyelaran, Daniel Egbule, Wayne Van Gemert, Lucy Mupfumi, Cleophas D’auvergne, Obioma Chijioke-Akaniro, Chukwuma Anyaike, Sunday Olarewaju","doi":"10.1101/2024.09.02.24312961","DOIUrl":null,"url":null,"abstract":"The uptake of TB preventive therapy (TPT) for child and adult contacts of index TB patients in Nigeria has been suboptimal. Nigeria introduced the 3-month isoniazid-rifampicin (3HR) shorter regimen TPT for all eligible contacts through the USAID-funded Stop TB Partnership introducing New Tools Project (iNTP). This study assesses the facilitators and barriers to the uptake of the newly introduced child-friendly 3HR TPT for child contacts of TB patients in Nigeria.","PeriodicalId":501509,"journal":{"name":"medRxiv - Infectious Diseases","volume":"35 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.02.24312961","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The uptake of TB preventive therapy (TPT) for child and adult contacts of index TB patients in Nigeria has been suboptimal. Nigeria introduced the 3-month isoniazid-rifampicin (3HR) shorter regimen TPT for all eligible contacts through the USAID-funded Stop TB Partnership introducing New Tools Project (iNTP). This study assesses the facilitators and barriers to the uptake of the newly introduced child-friendly 3HR TPT for child contacts of TB patients in Nigeria.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
